Patricia Giardina

Patricia Giardina

UNVERIFIED PROFILE

Are you Patricia Giardina?   Register this Author

Register author
Patricia Giardina

Patricia Giardina

Publications by authors named "Patricia Giardina"

Are you Patricia Giardina?   Register this Author

59Publications

1042Reads

29Profile Views

Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United States.

Pediatr Blood Cancer 2018 07 10;65(7):e27067. Epub 2018 Apr 10.

Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27067DOI Listing
July 2018

Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia.

Am J Hematol 2017 Dec 31;92(12):1356-1361. Epub 2017 Oct 31.

Department of Pediatrics & Thalassemia Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24914DOI Listing
December 2017

Late complications of mixed chimerism following allogeneic bone marrow transplantation for thalassemia major.

Pediatr Blood Cancer 2015 Jul 21;62(7):1303-4. Epub 2015 Mar 21.

Memorial Sloan-Kettering Cancer Center, Department of Pediatrics, Bone Marrow Transplant Service, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25498DOI Listing
July 2015

Red blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines.

Transfusion 2014 Jul 24;54(7):1773-81. Epub 2014 Feb 24.

Departments of Transfusion Medicine and Pediatrics, New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12571DOI Listing
July 2014

Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Transfusion 2014 Apr 25;54(4):972-81; quiz 971. Epub 2013 Jul 25.

Children's Hospital Oakland, Oakland, California; Centers for Disease Control and Prevention, Atlanta, Georgia; Weill Medical College of Cornell University, New York, New York; Children's Hospital Philadelphia, Philadelphia, Pennsylvania; Children's Hospital Los Angeles, Los Angeles, California; Children's Healthcare of Atlanta at Scottish Rite, Atlanta, Georgia; Boston Children's Hospital, Boston, Massachusetts; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410835PMC
April 2014

Negative affect differentiation and adherence during treatment for thalassemia.

Int J Behav Med 2014 Feb;21(1):160-8

Department of Psychology, Kent State University, P.O. Box 5190, Kent, OH, 44242-0001, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12529-012-9277-7DOI Listing
February 2014

The palatability and tolerability of deferasirox taken with different beverages or foods.

Pediatr Blood Cancer 2013 Sep 23;60(9):1507-12. Epub 2013 Apr 23.

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey 07601, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24561DOI Listing
September 2013

Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patients.

AIDS Res Hum Retroviruses 2013 Jul 12;29(7):1006-9. Epub 2013 Mar 12.

Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2012.0382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810841PMC
July 2013

Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease.

Pediatr Blood Cancer 2013 Apr 5;60(4):653-8. Epub 2012 Nov 5.

Department of Pediatrics, Division of General Pediatrics, Children's Hospital at Montefiore, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10467, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.24381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625668PMC
April 2013

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine.

Haematologica 2013 Jan 8;98(1):129-35. Epub 2012 Aug 8.

Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2012.070607DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533674PMC
January 2013

How I treat thalassemia.

Blood 2011 Sep 2;118(13):3479-88. Epub 2011 Aug 2.

Department of Hematology, Wolfson Medical Center, Holon, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-08-300335DOI Listing
September 2011

Follow-up report on the 2-year cardiac data from a deferasirox monotherapy trial.

Am J Hematol 2010 Oct;85(10):818-9

Department of Pediatrics and Radiology, Divisions of Cardiology and Radiology, Children's Hospital of Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21830DOI Listing
October 2010

Combined iron chelation therapy.

Ann N Y Acad Sci 2010 Aug;1202:79-86

Pediatric Clinic 2, University of Cagliari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2010.05591.xDOI Listing
August 2010

A preclinical approach for gene therapy of beta-thalassemia.

Ann N Y Acad Sci 2010 Aug;1202:134-40

Department of Pediatrics, Division of Hematology-Oncology, Weill Cornell Medical College, Children's Blood and Cancer Foundation Laboratories, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2010.05594.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068625PMC
August 2010

Hepcidin and Hfe in iron overload in beta-thalassemia.

Ann N Y Acad Sci 2010 Aug;1202:221-5

Division of Hematology-Oncology, Department of Pediatrics, Children's Cancer and Blood Foundation Laboratories, Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2010.05595.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652388PMC
August 2010

The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores.

Blood 2010 Jul 26;116(4):537-43. Epub 2010 Apr 26.

Children's Hospital of Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-11-250308DOI Listing
July 2010

Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator.

Br J Haematol 2007 Aug;138(3):374-81

Department of Gastroenterology, The Children's Hospital & Research Center Oakland, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2007.06651.xDOI Listing
August 2007

Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy.

Hum Gene Ther 2007 Jan;18(1):1-9

Gene Transfer and Gene Expression Laboratory, Department of Medicine and Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2006.151DOI Listing
January 2007

Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia.

Ann N Y Acad Sci 2005 ;1054:417-22

Weill Medical College of Cornell University, Department of Pediatrics, Division of Hematology-Oncology, Children's Blood Foundation Laboratories, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1196/annals.1345.069
Publisher Site
http://dx.doi.org/10.1196/annals.1345.069DOI Listing
July 2006

Low bone mineral density in adolescents with beta-thalassemia.

Ann N Y Acad Sci 2005 ;1054:462-6

Department of Pediatrics, New York-Presbyterian Hospital / Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1345.063DOI Listing
July 2006

Low bone mass in prepubertal children with thalassemia major: insights into the pathogenesis of low bone mass in thalassemia.

J Pediatr Endocrinol Metab 2004 Oct;17(10):1415-21

Department of Pediatrics, The New York-Presbyterian Hospital/Weill Medical College of Cornell University, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem.2004.17.10.1415DOI Listing
October 2004